does tirzepatide cause infertility Make You Fertile? Effects on Reproductive Health Does Tirzepatide Affect Fertility? Evidence

The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 28.7% weight loss at 68 weeks Reduced key cardiometabolic risk markers non-HDL cholesterol, triglycerides, and hsCRP Highest dose lowered systolic BP by 14 mmHg Reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function GI side effects most common adverse event We now await 7 additional phase 3 trials in other obesity related comorbidities

It is approved for specific indications including type 2 diabetes and chronic weight management

GRADE: LOW certainty)

The federal government and major drugmakers reach a landmark deal to dramatically cut GLP-1 drug prices, lowering costs for Medicare, Medicaid, and cash-paying patients.